Type 2 diabetes mellitus is a heterogeneous metabolic disorder characterized by impaired insulin secretion from pancreatic beta cells and insulin resistance in peripheral tissues such as liver, adipose tissue, and skeletal muscle. 1) Skeletal muscles account for approximately 75% of glucose absorption under insulin-stimulated conditions, and glucose transport is the rate-limiting step in primary glucose disposal and utilization especially in insulin-targeted skeletal muscle. Thus, its alteration is one of the major defects in type 2 diabetes both in vitro and in vivo. [2] [3] [4] Increased glucose transport in skeletal muscle is reported to be mediated by glucose transporter 4 (Glut4), which translocates into the plasma membrane in response to insulin. 5) The defect that causes type 2 diabetes has previously been shown to be a result of decreased intracellular Glut4 trafficking, 6) and increased expression of Glut4 in skeletal muscle lowers blood glucose and enhances glucose transport and glucose utilization in skeletal muscles, among other changes. [7] [8] [9] For these reasons, some targeted anti-diabetic drugs have been developed; for example, metformin (dimethylbiguanide), a commonly used glucose-lowering reagent, is thought to increase glucose uptake in skeletal muscle. 10) Rosiglitazone and pioglitazone both act by reducing glucose production in the liver and increasing insulin-dependent glucose uptake in muscle cells.
11)
Therefore, we investigated the anti-diabetic therapeutic potential of several compounds to maximize glucose transport in L6 myotubes, which have been widely used to study the mechanism of insulin-stimulated glucose transport.
Several tyrosine phosphatases have been implicated in the regulation of insulin action, particularly tyrosine phosphatase 1B.
12) Tyrosine phosphatase 1B is ubiquitously expressed and appears to be involved in the regulation of glucose homeostasis and energy expenditure by acting as a key negative regulator of insulin receptor (IR)-and insulin receptor substrate-1 (IRS-1)-mediated signaling pathways.
13) The recent identification of tyrosine phosphatase 1B has raised the possibility that small molecule inhibitors of this enzyme could act as insulin sensitizers and anti-diabetic drugs by increasing glucose transport. [14] [15] [16] Rhubarb is the rhizome of Rheum undulatum L., R. palmatum, R. tanguticum MAXIM., R. officinale BAILL., and R. coreanum NAKAI, which are distributed in Korea, Japan and China. The dried rhubarb rhizome is an important herbal medicine that is traditionally used for its purgation, antibacterial, anti-tumor, and anti-mutagenic properties and its ability to cure mental and renal disorders. 17, 18) It is known to contain bioactive components including anthraquinones, dianthrones, stilbenes, anthocyanins, flavonoids, tannins, organic acids, and chromones. The main bioactive constituents of rhubarb are anthraquinone derivatives that can inhibit cellular proliferation, induce apoptosis, and prevent metastasis. 19) However, anti-diabetic properties of rhubarb are less well studied. In the course of screening natural medicinal plants that cause increased glucose transport activity in basal-and insulin-stimulated L6 myotubes, we selected Korean rhubarb rhizome and isolated its bioactive compounds.
Thus, in this study, we sought to identify active compounds to improve glucose transport in myotubes and to evaluate their roles by measuring tyrosine phosphorylation of IR, tyrosine phosphatase 1B activity, and Glut4 expression. Our data collectively suggest that isolated compounds from rhubarb rhizome are potential diabetes therapeutics.
MATERIALS AND METHODS
Plant Material Cultivated Korean rhubarb rhizome was purchased from Yuseong herbal drug market, Daejeon, Korea. A voucher specimen has been deposited in Chungnam National University.
Extraction and Isolation The dried and milled rhizome of rhubarb (5 kg) was extracted with ethanol, three times. The ethanol extract was combined and concentrated to yield a residue (650 g), which was suspended in water and then successively partitioned with hexane (30 g), EtOAc (300 g) and BuOH (100 g). The EtOAc-soluble fraction was diluted with acetone, and then filtrated through filter paper to give precipitated powder and acetone fraction (226.1 g). The acetone fraction was subjected to silica gel column chromatography using the mixtures of CHCl 3 and MeOH in increasing polarity (80 : 1 to 0 : 1) to separate into six fractions (#1-#6). The subfraction #3 was rechromatographed on silica gel column with a stepwise gradient of CHCl 3 and MeOH (4 : 1 to 0 : 1) to give chrysophanol-8-O-b-D-glucopyranoside (1) (600 mg). The hexane-soluble fraction was subjected to silica gel column chromatography, eluted with hexane-EtOAc (60 : 1 to 0 : 1) to give five fractions (H#1-H#5). The fraction H#1 was rechromatographed on silica gel column, hexane-EtOAc (40 : 1) as eluting solvent to obtain chrysophanol (2) (1.5 g).
Cell Culture L6 rat myoblasts (CRL-1458TM) were obtained from ATCC (Rockville, MD, U.S.A.), cultured in DMEM containing 10% FBS, 100 units/ml penicillin and 100 mg/ml streptomycin, and incubated at 37°C under 5% CO 2 humidified atmosphere. 32D cells expressing insulin receptor (32D IR ) were grown and maintained in RPMI 1640 medium containing 10% FBS and 5% WEHI-conditioned medium to provide IL-3.
20)
Myotube Differentiation L6 myoblasts were seeded in 60 mm dishes (for Western blotting) or 12-well plates (for glucose uptake) at a density of 1ϫ10 5 cells/ml. After 24 h (about 90% confluence), the medium was switched to DMEM with 2% horse serum and replaced every second day. Experiments were initiated on day 6 when myotube differentiation was completed.
Glucose Transport Assay Myotubes were cultured on 12-well plates, incubated with serum-free DMEM for 18 h, and washed with Krebs-Ringer Hepes (KRH) buffer (NaCl 120 mM, KCl 5 mM, CaCl 2 2 mM, MgSO 4 1.5 mM, HEPES 20 mM). After compound treatment for 1 h, cells were treated with 200 nM insulin for 20 min and added 1 mCi 2-deoxy-D-[
3 H]-glucose and 5 mM glucose as final concentrations for an additional 15 min. The reaction was terminated by placing the plates on the ice, washing the cells three times with icecold PBS. The cells were lysed in 0.5 M NaOH with 0.1% SDS for 1-2 h at 37°C, and the radioactivity retained by cell lysates was determined by a scintillation counter.
21)
Tyrosine Phosphatase Assay Tyrosine phosphatase 1B (human, recombinant) was purchased from BIOMOL International LP (Plymouth Meeting, PA, U.S.A.). The inhibitory effect of compounds on enzyme activity was measured by a method described previously.
22)
Protein Extract and Western Blot Analysis 32D IR cells were washed with cold PBS containing 1 mM Na 3 VO 4 . The pellet was suspended in extraction buffer (10 mM Tris, pH 7.4, 150 mM NaCl, 0.5% NP-40, 1 mM EDTA, 1% Triton X-100, 1 mM PI, 1 mM Na 3 VO 4 ), and protein concentration was determined with Bio-Rad Protein Assay Reagent. Equal amounts of protein were subsequently fractionated by 10% SDS-PAGE and transferred to a polyvinylidene difluoride (PVDF) membrane. The blotter was blocked in 5% skim milk diluted in TBS containing 0.1% Tween-20 for 1 h then incubated with primary antibody, anti-P-Tyr (1 : 1000) (Upstate, Temecula, CA, U.S.A.), followed by incubation with anti-rabbit horseradish peroxidase-conjugated IgG (1 : 2000) and visualized with enhanced chemiluminescence. The bands of IRb (97 kDa) were confirmed by anti-IRb antibody (Santa Cruz Biotechnology, Santa Cruz, CA, U.S.A.).
RNA Isolation and Reverse Transcription-Polymerase Chain Reaction (RT-PCR) After vehicle and drug treatment, cells were subjected to total RNA isolation by using RNAeasy mini kit. RNA concentrations were determined by measuring absorption at 260 nm in a spectrophotometer. Aliquots of 1 mg of total RNA from each sample were reverse transcribed to cDNA using an AccuPower ® CycleScript RT PreMix (dT20) according to manufacturer's instructions from Bioneer Inc. (Daejeon, Korea). PCR primers used in this study included; Glut4: 5Ј-CGG GAC GTG GAG CTG GCC GAG GAG-3Ј and 5Ј-CCC CCT CAG CAG CGA GTG A-3Ј; Gapdh: 5Ј-TAG ACG GGA AGC TCA CTG GC-3Ј and 5Ј-AGG TCC ACC ACC CTG TTG CT-3Ј.
Cell Cytotoxicity L6 myoblasts were seeded at 5ϫ10 3 cells/well in 96-well microplates and allowed to attach for 24 h. Compounds were added to the medium at various concentrations (0 to 100 mM). After 48 h treatment, cell proliferation and cytotoxicity were conducted by Cell Counting Kit-8 (Dojindo Laboratories, Tokyo, Japan). CCK-8 (10 ml) was added to each well and incubated for 3 h at 37°C, then assessed by measuring the absorbance at 450 nm using microplate reader (Dynatech MR700). Three replicated wells were used for each experimental condition.
RESULTS AND DISCUSSION
In the present study, we employed L6 myotubes to evaluate the effect of 56 medicinal plants on glucose transport; we ultimately selected Korean rhubarb rhizome. Plant medicines have a long history as treatments for diabetes, and numerous phytotherapies to manage risk factors such as hyperglycemia have been investigated in animal models and patients over the years. 23 ) Muscular glucose transport activity-guided isolation of bioactive compounds from rhubarb rhizome yielded chrysophanol-8-O-b-D-glucopyranoside (1) from the EtOAcsoluble fraction and its aglycone chrysophanol (2) from the hexane-soluble fraction (Fig. 1) . In studies of diabetes, chrysophanol-8-O-b-D-glucopyranoside has been reported to prevent hyperglycemia-associated diabetes through its mammalian intestinal a-glucosidase inhibitory activity, while chrysophanol inhibited postprandial hyperglycemia by 42.3%. 23, 24) To assess the anti-diabetic effect of the isolated compounds, we first conducted glucose transport assays with var- Treatment with up to 10 mM compound 1 alone (basal level) did not influence the activity, while the activity was slightly increased to 132 and 131% at 25 and 50 mM, respectively ( Fig. 2A) . Compound 2 increased the activity to 141, 174, and 177% at doses of 10, 25 and 100 mM, respectively, in insulin-stimulated L6 myotubes, with no detectable changes in basal level (Fig. 2B) . Our results suggest that compounds 1 and 2 affect insulin-stimulated muscular glucose transport and could be used as insulin sensitizers for diabetes treatment.
To investigate the role of compounds with IR-regulated glucose transport activity, we assessed tyrosine phosphatase 1B in vitro. As a critical negative regulator of the insulin signal transduction cascade, tyrosine phosphatase 1B acts to reverse tyrosine kinase action and is a key phosphatase for IR and IRS-1, major mediators of the glucose transport pathways. 25, 26) Tyrosine phosphatase 1B has also been implicated in insulin-dependent pathways and in the insulin insensitivity that is the most common pathology of type 2 diabetes and obesity.
27) Therefore, we measured the tyrosine phosphatase 1B inhibitory activity of the isolated compounds. The results are shown in Table 1 ; compounds 1 and 2 inhibited this enzyme with IC 50 values of 18.34Ϯ0.29 and 79.86Ϯ0.12 mM, respectively ( Table 1 ). The anthraquinones from Saussurea lappa, emodin-8-O-b-D-glucopyranoside, rhein-8-O-b-D-glucopyranoside and chrysophanol, were reported to be moderate inhibitors against tyrosine phosphatase 1B in vitro. 28) Similarly, compound 2 exhibited moderate inhibitory activity in this study, but compound 1 has not previously been reported to be a potent inhibitor of tyrosine phosphatase 1B. To further identify whether both compounds could inhibit tyrosine phosphatase 1B in cells, we tested the tyrosine phosphorylation levels of IR using 32D IR cells. Treatment of cells with compounds 1 and 2 resulted in increased insulin-stimulated IR tyrosine phosphorylation (Figs. 3A, B) . These results suggest that the reduction activity of tyrosine phosphatase 1B activity by compounds 1 and 2 could influence glucose transport activity through consistent phosphorylation on its specific substrate, the insulin receptor.
The effect of the compounds on Glut4-mediated glucose transport and mRNA expression was analyzed by RT-PCR. Increased Glut4 expression in previous studies enhanced glucose transport in skeletal muscles. [7] [8] [9] As shown, compound 2, dose-dependently increased the Glut4 mRNA level by 1.16-(1 mM), 1.24-(10 mM), 1.34-(25 mM) and 1.42-fold (100 mM) (Fig. 4A) . However, the level of Glut4 remained constant after compound 1 treatment (Fig. 4B) , showing that this compound had not increase glucose transport by affecting Glut4 expression.
Finally, we observed the cellular toxicity of two compounds; compounds 1 and 2 showed mild cytotoxicity against undifferentiated myoblasts with ED 50 values of 59.38Ϯ0.66 and 79.69Ϯ0.03 mM, respectively (Table 2) .
In summary, two anthraquinones that affected glucose transport in myotubes with mild cytotoxicity were isolated from Korean rhubarb rhizome. Chrysophanol-8-O-b-D-glucopyranoside significantly enhanced insulin-stimulated glucose transport by IR activation, but did not influence Glut4 expression. Chrysophanol influenced insulin-responsive glucose transport by increasing IR phosphorylation and Glut4 mRNA expression. The results suggest that chrysophanol-8- O-b-D-glucopyranoside and chrysophanol could be considered as potential therapeutic reagents for diabetes due to their enhancing effects on insulin-dependent glucose transport. Further studies are needed to clarify their additional effects. 
